Precision Biosciences Inc (DTIL) insider trading
Every open-market stock purchase and sale by Precision Biosciences Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Geno J Germano (Director) and 2 others bought $29.5K in the last 90 days, growing their stake 6%.
Last 12 months: insiders bought $63.2K (6 buys) and sold $466K (11 sales). Last close $6.71 on Oct 21, 2026.
Recent DTIL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | Stanley Frankel (Director) | Bought | $6K |
| Sep 25, 2026 | Geno J Germano (Director) | Bought | $16.4K |
| Sep 25, 2026 | Melinda Brown (Director) | Bought | $7.1K |
| Jun 3, 2026 | Stanley Frankel (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Geno J Germano (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Shari Lisa Pire (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Melinda Brown (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Kevin Buehler (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Dario Scimeca (General Counsel) | Bought (not open market) | — |
| Jun 1, 2026 | Michael Amoroso (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | John Alexander Kelly (CFO) | Bought (not open market) | — |
| Jun 1, 2026 | J. Jefferson Smith (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Melinda Brown (Director) | Bought (not open market) | — |
| May 20, 2026 | Kevin Buehler (Director) | Bought (not open market) | — |
| May 20, 2026 | Stanley Frankel (Director) | Bought (not open market) | — |
| May 20, 2026 | Geno J Germano (Director) | Bought (not open market) | — |
| May 20, 2026 | Shari Lisa Pire (Director) | Bought (not open market) | — |
| Feb 18, 2026 | Michael Amoroso (CEO) | Sold | $78.9K |
| Feb 18, 2026 | John Alexander Kelly (CFO) | Sold | $31.3K |
| Feb 18, 2026 | Dario Scimeca (General Counsel) | Sold | $18.9K |
| Feb 18, 2026 | J. Jefferson Smith (C-suite exec) | Sold | $18.9K |
| Feb 17, 2026 | Dario Scimeca (General Counsel) | Bought (not open market) | — |
| Feb 17, 2026 | John Alexander Kelly (CFO) | Bought (not open market) | — |
| Feb 17, 2026 | Michael Amoroso (CEO) | Bought (not open market) | — |
| Feb 17, 2026 | J. Jefferson Smith (C-suite exec) | Bought (not open market) | — |
Who's trading DTIL
- Stanley Frankel, Director: bought $18.7K (2 buys), last Sep 28, 2026
- Melinda Brown, Director: bought $14K (2 buys), last Sep 25, 2026
- Geno J Germano, Insider: bought $30.5K (2 buys), last Sep 25, 2026
- Shari Lisa Pire, Insider: other filings, last Jun 3, 2026
- Kevin Buehler, Insider: other filings, last Jun 3, 2026
- Michael Amoroso, CEO: sold $246K (3 sales), last Jun 1, 2026
- John Alexander Kelly, CFO: sold $101K (3 sales), last Jun 1, 2026
- J. Jefferson Smith, C-suite exec: sold $60K (2 sales), last Jun 1, 2026
- Dario Scimeca, General Counsel: sold $58.9K (3 sales), last Jun 1, 2026
Get free alerts when an insider at Precision Biosciences Inc files a new trade →